Download presentation
Presentation is loading. Please wait.
Published byMadlyn Byrd Modified over 6 years ago
1
Deferasirox Decreases Liver Iron Concentration in Iron-Overloaded Patients with Myelodysplastic Syndromes, Aplastic Anemia and Other Rare Anemias Acta Haematol 2015;134: DOI: / Fig. 1. Patient disposition. © 2015 S. Karger AG, Basel - CC BY-NC 3.0
2
Deferasirox Decreases Liver Iron Concentration in Iron-Overloaded Patients with Myelodysplastic Syndromes, Aplastic Anemia and Other Rare Anemias Acta Haematol 2015;134: DOI: / Fig. 2. Mean change in LIC and after 1 year (a) and 2 years (b) of treatment, by underlying anemia, in Japanese and non-Japanese patients. © 2015 S. Karger AG, Basel - CC BY-NC 3.0
Similar presentations
© 2024 SlidePlayer.com Inc.
All rights reserved.